FDA OKs 1st targeted drug for common lung cancer mutation
Biden marks vaccine progress, thanks troops ahead of holiday
28 May 2021Depressive symptoms linked to rapid kidney function decline
29 May 2021FDA OKs 1st targeted drug for common lung cancer mutation
U.S. regulators have approved the first medicine for patients with the most common type of lung cancer whose tumors have a genetic mutation long considered untreatable with drugs.
